Parkinson's disease can be caused by mutations in the a-synuclein gene and is characterized by aggregates of a-synuclein protein. We have previously shown that overexpression of the small GTPase Rab7 can induce clearance of a-synuclein aggregates. In this study, we investigate which Rab7 effectors mediate this effect. To model Parkinson's disease, we expressed the pathogenic A53T mutant of a-synuclein in HEK293T cells and Drosophila melanogaster. We tested the Rab7 effectors FYVE and coiled-coil domaincontaining protein 1 (FYCO1) and Rab-interacting lysosomal protein (RILP). FYCO1-EGFP-decorated vesicles containing a-synuclein. RILP-EGFP also decorated vesicular structures, but they did not contain a-synuclein. FYCO1 over-expression reduced the number of cells with a-synuclein aggregates, defined as visible particles of EGFP-tagged a-synuclein, whereas RILP did not. FYCO1 but not RILP reduced the amount of a-synuclein protein as assayed by western blot, increased the disappearance of a-synuclein aggregates in time-lapse microscopy and decreased a-synuclein-induced toxicity assayed by the Trypan blue assay. siRNA-mediated knockdown of FYCO1 but not RILP reduced Rab7-induced aggregate clearance. Collectively, these findings indicate that FYCO1 and not RILP mediates Rab7-induced aggregate clearance. The effect of FYCO1 on aggregate clearance was blocked by dominant negative Rab7 indicating that FYCO1 requires active Rab7 to function. Electron microscopic analysis and insertion of lysosomal membranes into the plasma membrane indicate that FYCO1 could lead to secretion of asynuclein aggregates. Extracellular a-synuclein as assayed by ELISA was, however, not increased with FYCO1. Coexpression of FYCO1 in the fly model decreased a-synuclein aggregates as shown by the filter trap assay and rescued the locomotor deficit resulting from neuronal A53T-a-synuclein expression. This latter finding confirms that a pathway involving Rab7 and FYCO1 stimulates degradation of a-synuclein and could be beneficial in patients with Parkinson's disease.
or by duplication of the a-synuclein locus, and the asynuclein locus is a genetic risk factor for sporadic PD. Therefore, removing a-synuclein aggregates is a plausible strategy to stop disease progression in PD. We have recently shown that the small GTPase Rab7 is rate-limiting for autophagic clearance and that over-expression of Rab7 increases the maturation of a-synuclein-containing autophagosomes (Dinter et al. 2016) . Rab7 recognizes late endosomes and autophagosomes by binding to the membrane lipid phosphatidylinositol 3-phosphate (Dall'armi et al. 2013) . Rab7 then recruits further proteins that determine the fate of the Rab7-decorated vesicle (Hutagalung and Novick 2011; Bento et al. 2013) . These Rab7 effectors include the Rab-interacting lysosomal protein (RILP) and the FYVE and coiled-coil domain-containing protein 1 (FYCO1).
RILP was identified as a Rab7 interactor required for Rab7-dependent lysosomal degradation of endosomes carrying epidermal growth factor (EGF) or low-density lipoprotein (LDL) (Cantalupo et al. 2001) . Dynein is a protein complex mediating transport along microtubules towards their minus end, which is located at the perinuclear microtubuleorganizing centre (MTOC). Rab7-decorated endosomes recruit dynein motors through formation of a protein complex consisting of RILP, the dynein component p150 Glued , oxysterol-binding protein-related protein 1L (ORP1L) and bIII spectrin (Jordens et al. 2001; Johansson et al. 2007) . Dominant negative dynein inhibited a-synuclein clearance (Ravikumar et al. 2005) . It is therefore plausible to hypothesize that RILP recruits dynein motors to Rab7-decorated autophagosomes for minus-end directed transport and fusion with lysosomes at the MTOC.
FYCO1 contains a kinesin-binding domain, has been shown to form molecular complexes with Rab7 and LC3, and was found on membranes of late endosomes, autophagosomes and lysosomes (Pankiv et al. 2010) . Kinesin motor proteins mediate transport on microtubules towards the cell periphery, and FYCO1 on late endosomes was recently shown to obtain kinesin-1 through contact sites with the endoplasmic reticulum (ER) that depend on Rab7 and the ER protein protrudin (Raiborg et al. 2015) . Accordingly, FYCO1-mCherry moved along microtubules towards the cell periphery, and over-expression of FYCO1-mCherry showed vesicular structures that were often clustered and located in the cell periphery (Pankiv et al. 2010) . FYCO1 through its LC3-interacting region (LIR) motif was shown to be important for the fusion of autophagosomes with lysosomes (Olsvik et al. 2015) and for the fusion of late endosomes with the plasma membrane (Raiborg et al. 2015) .
In this study, we investigate the involvement of RILP and FYCO1 in Rab7-induced clearance of a-synuclein aggregates. Since RILP induces dynein-mediated transport towards the MTOC, whereas FYCO1 induces kinesinmediated transport towards the cell periphery, we expect from our findings also a better mechanistic understanding of the cellular trafficking steps required for clearance of a-synuclein aggregates.
Methods
Cell culture and transfection HEK293T (RRID:CVCL_0063) cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 1% penicillin-streptomycin. 'HEK' cells are listed in version 8.0 of the Database of Cross-Contaminated or Misidentified Cell Lines. Our HEK293T cells were validated in November 2017 by analysis of 21 genetic loci (Promega, Madison, WI, USA, PowerPlex 21 PCR Kit carried out by Eurofins Medigenomix Forensik, Ebersberg, Germany).
Cells were plated on poly-L-lysine-coated glass cover slips or on plastic plates. Transfection was done 18-20 h after plating using Metafectene (Cat# T020-5.0 Biontex Laboratories, Munich, Germany). Unless noted otherwise, subsequent analysis was done 24 h after transfection. Lysotracker Red (Cat# L-7528 Thermo Fisher, Cambridge, UK) was used at a 75 nM final concentration and was incubated for 2 h at 37°C before acquiring images of live cells. Trypan blue staining and analysis was carried out as previously described (Dinter et al. 2016) .
siRNA for FYCO1, RILP and firefly luciferase (LUC) as a control were obtained from Sigma-Aldrich (Cat# EHU134361, EHU024401 and EHUFLUC Mission esiRNA). Cells were seeded in six-well plates and transfected with 1.6 lg of siRNA per well. On the next day, cells were split to coverslips in 24-well plates. After culturing for 24 h, cells were transfected with the appropriate plasmids and again with 400 ng siRNA per well. Cells were analysed 24 h later. Efficiency of siRNA-mediated knockdown was confirmed by immunoblots ( Figure S1 ).
Plasmids
A53T-a-synuclein flexibly tagged with PDZ-EGFP achieved through the interaction of the PDZ domain with its six aminoacidbinding motif at the C-terminus of a-synuclein was described in Opazo et al. (2008) . The mCherry version was described in Dinter et al. 2016 . GFP-tagged human Rab7A (WT and T22N in pEGFP-C1) were gifts from Richard Pagano (Addgene plasmids #12605 and 12660). For simplicity, we refer to Rab7A as Rab7. A Rab7 variant without GFP tag was created by inserting the Rab7 open reading frame amplified with sites for NheI and XbaI added to the primers into pcDNA 3.1 (primers 1 and 2 in Table 1 ). pHluorin-LAMP1-mCherry plasmid was a kind gift of Camilla Raiborg (Raiborg et al. 2015) . The cDNA of RILP and FYCO1 were obtained from the IMAGE library through BioCAT (Heidelberg, Germany). GFP-RILP and mCherry-RILP were created by inserting the RILP open reading frame (IMAGE clone #BC031621) amplified with sites for EcoRV and NotI added to the primers in pcDNA 3.1 plasmids in which GFP, respectively, mCherry was inserted using KpnI and EcoRV (primers 3-6 in Table 1 ). FYCO1-GFP, FYCO1-mCherry and FYCO1-CFP were obtained by cloning the FYCO1 open reading frame (IMAGE clone #BC101468) amplified with sites for BglII and KpnI added to primers into the pEGFP-N1, pmCherry-N1 and pCFP-N1 backbones respectively (primers 7 and 8 in Table 1 ).
The 2xteto A53T-a-synuclein PDZ-EGFP plasmid for inducible expression of a-synuclein was created so that there is a tetracycline inducible promoter (teto) before both A53T-a-synuclein (with PDZ-binding motif) and PDZ-EGFP. Firstly, the CMV-teto cassette from pcDNA5/FRT/TO plasmid was amplified using primers adding EcoRV and AfeI digestion sites and replaced the CMV promoter before PDZ-EGFP (primers 9 and 10 in Table 1 ). In a second step, HindIII and XhoI enzymes were used to take out A53T-a-synucleinteto-PDZ-EGFP and insert it into the pcDNA5/FRT/TO plasmid.
The pUAST-FYCO1 plasmid used to create transgenic flies was created by subcloning the FYCO1 open reading frame from the IMAGE clone #BC101468 into the pUAST vector backbone using KpnI and XbaI restriction enzymes (primers 11 and 12 in Table 1 ).
Immunoblot analysis
Immunoblots were carried out as previously described (Dinter et al. 2016) : Cells were washed and lysed 24 h after transfection. Thirty micrograms of protein was subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and blotted onto nitrocellulose membranes. Primary antibodies were incubated over night at 4°C and horseradish peroxidase-conjugated secondary antibodies were incubated for 2 h at 21°C. Detection was carried out by chemiluminescence (Cat# 34580 9 4 SuperSignal West Pico Chemiluminescent Substrate, Thermo Fisher Scientific, Rockford, USA). The following antibodies were used: rabbit anti-a-synuclein (1 : 500, Cat# 2642, RRID:AB_2192679, Cell Signalling Technology, Danvers, USA), mouse anti-beta-tubulin (1 : 1000, Cat# E7, RRID:AB_528499, Developmental Studies Hybridoma Bank, Iowa, USA), mouse anti-actin (1 : 1000, Cat# ab40864, RRID:AB_722536 Abcam, Cambridge, UK), mouse anti-DsRed (1 : 2000, Cat# 632496, RRID:AB_10013483 Living Colors â DsRed Polyclonal Antibody, Takara Bio Europe), mouse anti-HA (1 : 1000, F-7 Cat# sc-7392, Santa Cruz, Heidelberg, Germany), anti-mouse IgG (Cat# NXA931, RRID:AB_772209) and anti-rabbit IgG (Cat# NA9340, RRID:AB_772191) from GE Healthcare Life Sciences (1 : 10 000 Munich, Germany). Blots incubated with the a-synuclein antibody from Cell Signalling showed an unspecific band around 35 kD and two bands around 20 kD. The upper 20 kD band was seen only in cells transfected with a-synuclein; thus, we consider this band to represent asynuclein. Bands were quantified using the Software BioDocAnalyze (Biometra, G€ ottingen, Germany) as described previously (Dinter et al. 2016) .
Microscopy of fixed cells
Analysis was carried out as previously described (Dinter et al. 2016) . For the classification of EGFP distribution patterns, cells were grown and transfected on coverslips. Twenty-four hours after transfection, cells were washed three times in cold phosphatebuffered saline (PBS) and fixed with PFA (4% paraformaldehyde, 5% sucrose in PBS) for 10 min. Coverslips were mounted with Fluoromount-G (Cat# 0100-01 Southern Biotech, AL, USA). Using fluorescence microscopy (Olympus BX51 microscope, 60 9 oil objective, NA 1.35 Hamburg, Germany) the EGFP distribution pattern was classified manually into the following categories: 'homogenous', 'one aggresome' (large, round, perinuclear aggregate), 'aggresome and aggregates', 'many aggregates' and 'unhealthy' (round, condensed cells). A blinded investigator classified at least 100 cells per coverslip. In each experiment, three coverslips were evaluated per experimental group and the results averaged. Depicted graphs summarize data (mean AE SEM) from different experiments with 'n' equal to the number of independent experiments summarized. For confocal images, we used a Zeiss LSM700 microscope with a 60 9 Oil objective (NA 1.35 Jena, Germany). Images were deconvolved using Huygens 4.2. (RRID:SCR_014237 Scientific Volume Imaging B.V., Hilversum, Netherlands) if noted in the legend (40 maximum iterations, signal-to noise ratio 20). Cropping and intensity adjustment was done using ImageJ 1.46 (RRID: SCR_003070 National Institutes of Health, USA).
Time-lapse microscopy Analysis was carried out as previously described (Opazo et al. 2008; Dinter et al. 2016) . Cells were grown in 24-well plates with glass bottom (Cat# 662892 Greiner bio-one, Frickenhausen, Germany). We used an Olympus IX81 epifluorescence microscope (Olympus xcellence software, 409 air objective, NA 0.9) equipped with an incubator (37°C, 5% CO 2 ) and a motor stage to acquire images at defined positions every 30 min over 12 h. Changes in cell appearance were classified manually based on the resulting videos blinded for the experimental group. For simplicity, we discriminated only cells with homogenous distribution of fluorescence, cells with any kind of aggregates and cells undergoing apoptosis. Apoptosis was defined as the disintegration of a cell into many small apoptotic . In the F1-progeny, we selected for males with pan neural A53T-asynuclein expression and concomitant expression of FYCO1 and GFP respectively (elav > A53T-a-synuclein, FYCO1 and elav > A53T-a-synuclein, GFP).
Expression in fly neurons of two copies of A53T-a-synuclein fused to the N-terminal (VN) fragment and to the C-terminal fragment (VC) of the fluorescent protein venus was achieved by genetically crossing and recombining flies carrying GAL4 under the elav promoter and flies expressing VN-tagged and VC-tagged A53T-a-synuclein under the UAS promoter. ; P {GD4261}v13673, were used as control in experiments conducted with the 'VN/VC' flies. These flies have been shown to have no effect in genetic screens for modifiers in neurodegenerative disease models.
All flies were raised and maintained at 25°C under a 12-h dark/ light cycle.
Fly climbing assay
Negative geotaxis (climbing) analysis was performed 5, 15 and 25 days post eclosion. In brief, groups of 10 male flies per vial (2.5 cm diameter) were gently tapped to the bottom and the number of flies crossing a line at 8 cm height within a time period of 10 s was scored. For each time point, at least 150 flies per genotype were analysed.
Analysis of fly lysates
For the fly head filter trap assay, virgins of the 'VC/VN' stock were crossed to males of either the w[118];;P{w[+]=UAS-FYCO1} or w [1118]; P{GD4261}v13673 (control) genotype. In the F1-progeny, we selected for males with pan neural A53T-a-synuclein and concomitant FYCO1 and always early RNAi expression respectively (elav > A53T-a-synucleinVN/VC, FYCO1 and elav > A53T-asynucleinVN/VC, alwaysearly RNAi). Ten fly heads were homogenized in 100 lL Radioimmunoprecipitation assay buffer (RIPA) buffer using the Speedmill P12 (Analytik Jena AG). The lysates were centrifuged at 13 800 g for 10 min at 4°C and the supernatant collected. For the filter trap assay, 5 lg of RIPA fly head lysates were adjusted to equal volumes. An equal volume of Urea buffer (8M) was subsequently added, samples were incubated rolling at 4°C for 1 h and sonicated in a water bath for 10 min. SDS and dithiothreitol were added at final concentrations of 2% and 50 mM. Using a dot blot filtration unit, the resulting solutions were filtered through a 0.2 lm nitrocellulose membrane (Cat# 10600001, GE Healthcare Life Sciences) previously equilibrated with 0.1% SDS in tris-buffered saline and afterwards washed in tris-buffered saline with Tween20 Membranes were further treated as an immunoblot described above.
Sample processing for transmission electron microscopic studies For transmission electron microscopic studies, the following cell lines were used: Fig Cells grown in culture dishes were gently scraped, centrifuged at 500 g and washed with PBS (21°C). Subsequently, cells were fixed with 2.5% glutaraldehyde (Sigma Cat# G5882) in 0.1 M phosphate buffer for 16 h. Cell pellets were collected by sedimentation and embedded in 2% agarose (Fluka Cat# 05073) at 60°C. Embedded cells were sliced and post-fixed in 2.5% glutaraldehyde (Sigma Cat# 1042390250) for 24 h, followed by two washing steps using 0.1 M phosphate buffer (each for 12 h). Afterwards, blocks were incubated in 1% OsO 4 (Sigma Cat# 75632) (in 0.2 M phosphate buffer) for 3 h, washed twice with distilled water and dehydrated using ascending alcohol concentrations (25%, 35%, 50%, 70%, 85%, 95% and 100%; each step for 5 min) followed by incubation in propylenoxide (Sigma Cat# 82320). Subsequently incubation in a 1:1 mixture of epon (47.5% glycidether (Sigma Cat# A32608), 26.5% dodecenylsuccinic acid anhydride (Sigma Cat# 443271), 24.5% methylnadic anhydride (Sigma Cat# 45347) and 1.5% Tris) and propylenoxide. Prepared samples were then incubated with epoxy resin (Sigma Cat# A3183) for 1 h at 21°C followed by polymerization (28°C for 8 h, 80°C for 2.5 h and finally 21°C for 4 h). After preparation of ultra-thin sections (70 nm), they were mounted on grids and samples were examined using a Philips CM10 transmission electron microscope (Philips Electron Optics, Eindhoven, The Netherlands).
Experimental design and statistical analysis
The study was not pre-registered. For assignment of experimental groups, no special randomization methods were employed. Sample sizes, that is,the number of cells classified per coverslip or thenumber of flies rated in the climbing assay, were determined by past experience and not by a statistical sample size calculation. The experiments reported in this work did not require institutional approval.
For statistical analysis and data presentation, we used GraphPad Prism 5.0 and 6.0 (RRID:SCR_002798, GraphPad Software, La Jolla, CA, USA). Graphs represent mean AE SEM. The test used for comparison in each graph and the number of independent experiments summarized are noted in the figure legend. Two groups were compared by t-test ( Fig. 8e and f) . Multiple groups were compared by one-way ANOVA and Holm-Sidak's post hoc test (Figs 6b and c,  8d ). Following Two-way ANOVA, Sidak's post hoc test was used if only two columns were compared (Figs 3a and b, 9a ). Dunnett's post hoc test was used if multiple columns were compared to a control column (Figs 1b and c, 5 ). Tukey's post hoc test was used in all other cases, each cell mean was then compared to every other cell mean with the same EGFP distribution pattern (Figs 3c, 4a and c). p < 0.05 was considered significant. In graphs, p values are depicted as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s., no significant difference.
Results

RILP is not associated with a-synuclein particles
We expressed the pathogenic A53T mutant of a-synuclein flexibly tagged by the fluorescent proteins GFP or mCherry in HEK293T cells. Flexible tagging uses the interaction of a six amino acid PDZ binding motif added to the C-terminus of a-synuclein with the corresponding PDZ domain and offers the advantage that aggresomes, aggregates and vesicular asynuclein particles can be readily observed in live and fixed cells. Aggresomes are large, perinuclear clusters of aggregates formed by dynein-mediated transport of aggregates towards the MTOC and characterized by vimentin and ctubulin staining as demonstrated previously for this paradigm (Kopito 2000; Opazo et al. 2008; Dinter et al. 2016) .
As a first step towards understanding the role of RILP for aggregate clearance, we expressed RILP-EGFP with mCherry-tagged A53T-a-synuclein (Fig. 1a) . RILP was observed on the perimeter of vesicular structures, but it did not associate with a-synuclein particles.
Secondly, we expressed EGFP-tagged A53T-a-synuclein and manually classified the EGFP distribution in transfected cells into the following three categories: cells with a homogenous distribution of EGFP ('homogenous', Fig. 1b) , cells showing bright fluorescent particles (Fig. 1c ) and rounded cells ('unhealthy', Fig. 1c) . Among the cells with bright particles, we discriminated between cells containing an aggresome only, an aggresome and other aggregates, or aggregates only without an aggresome. Unhealthy cells undergo apoptotic cell death when followed by time-lapse microscopy (Opazo et al. 2008) . This cell classification assay has been used in previous studies (Opazo et al. 2008; Karpinar et al. 2009; Krumova et al. 2011; Dinter et al. 2016) to determine differences between asynuclein variants and the effects of therapeutic manipulations. Under control conditions, about 40% of cells were in the homogenous category. As described previously (Dinter et al. 2016) , coexpression of Rab7 with a-synuclein increased the percentage of cells with a homogenous distribution of fluorescence, that is without a-synuclein aggregates. Coexpression of RILP decreased the percentage of cells with a homogenous distribution (Fig. 1b) and increased cells 'with an aggresome and aggregates' and 'unhealthy' cells (Fig. 1c) . This finding indicates that RILP availability does not represent a ratelimiting step for aggregate clearance.
RILP knockdown also reduced the percentage of cells with a homogenous distribution (Fig. 1b) and increased 'unhealthy' cells (Fig. 1c ), but to a lower degree than RILP over-expression. However, and most importantly RILP knockdown did not reduce the Rab7 effect, that is, it did not prevent the increase in cells with a homogenous fluorescence distribution induced by Rab7 over-expression (Fig. 1b) . This indicates that RILP does not mediate the aggregate clearance induced by Rab7 over-expression. RILP over-expression and RILP knockdown by siRNA was confirmed by western blot (Fig. 6a and Figure S1 ).
FYCO1 is enriched around a-synuclein aggregates Since RILP did not mediate the Rab7 effect, we investigated the role of FYCO1 using the same methodology. FYCO1-EGFP, as previously described (Pankiv et al. 2010) , was found at the perimeter of vesicular structures that were often clustered and located mostly in the periphery of the cell (Fig. 2a) . We could also confirm that the majority but not all lysotrackerpositive vesicles were labelled with FYCO1 ( Fig. 2a) and that there was a partial colocalization with LAMP1 (Fig. 2b) . When coexpressing FYCO1-EGFP with mCherry-tagged A53T-a-synuclein, a-synuclein was observed inside clustered vesicular structures labelled by FYCO1-EGFP (Fig. 2c) . In addition, FYCO1-EGFP-positive dots were found in the region of the aggresome (Fig. 2d) . These cells represented a small fraction of the transfected cells (< 10%); the majority of cells with FYCO1 expression displayed a homogenous distribution of a-synuclein (see next paragraph).
FYCO1 reduces a-synuclein aggregates
Given the association of FYCO1-EGFP with a-synuclein particles, we tested whether FYCO1 over-expression changes the number of cells with and without a-synuclein particles. For this, we coexpressed FYCO1-mCherry with EGFPtagged A53T-a-synuclein. FYCO1 significantly increased the proportion of cells with a homogenous distribution of a-synuclein and decreased cells with a-synuclein particles (Fig. 3a-c) . This increase was similar in size to the increase observed with Rab7 over-expression (Fig. 3d) .
Interestingly enough, knocking down FYCO1 ( Figure S1 ) diminished the ability of Rab7 to increase the number of cells with a homogenous distribution of a-synuclein (Fig. 3d) . Rab7 over-expression also did not change proportions between the different types of a-synuclein particles (Fig. 3e) when FYCO1 was knocked down. Over-expressing FYCO1 in addition to Rab7 showed more cells with a homogenous distribution of a-synuclein than with Rab7 alone (Fig. 4a) , but also more than with FYCO1 alone (Fig. 4a , two-way ANOVA and Tukey's post hoc test). This indicates that active Rab7 is rate-limiting for the FYCO1 effect. Looking into the cells with particles, we could observe that Rab7 or FYCO1 alone reduced mainly aggresomes, whereas the combination showed a prominent reduction in the 'aggresome and aggregates' and 'many aggregates' categories (Fig. 4b) . Consistent with a dependence of the FYCO1 effect on Rab7, the Rab7 dominant negative (DN) form (T22N) abolished the ability of FYCO1 to increase the number of cells without particles (Fig. 4a) . It is noteworthy that while over-expressed Rab7 and FYCO1 completely colocalized, the dominant negative Rab7 form has a more cytoplasmic localization, as previously described by others (Gutierrez et al. 2004) , and is not recruited to FYCO1-positive vesicles. (Fig. 4c) .
These findings are in agreement with the current knowledge that FYCO1 is a Rab7 effector protein (Pankiv et al. 2010 ) and indicate that it requires an active form of Rab7 in order to exert its function. Conversely, it appears that FYCO1 is required for the Rab7 effect on A53T-a-synuclein aggregates, suggesting that FYCO1 is the Rab7 effector mediating Rab7-induced aggregate clearance.
FYCO1 induces clearance of a-synuclein aggregates
We then went on to confirm the findings of the steady-state classification, and to visualize whether there is decreased formation of a-synuclein particles, increased clearance or both. For this we carried out time-lapse microscopy in cells expressing EGFP-tagged A53T-a-synuclein as previously (Opazo et al. 2008; Dinter et al. 2016) together with RILP or FYCO1. Changes in cell appearance were classified manually based on videos resulting from images acquired every 30 min over 12 h using the categories homogenous distribution of fluorescence, cells with particles, and cells undergoing apoptosis (this category replaces 'unhealthy' because in time-lapse microscopy, we can observe apoptotic cell death). Example images of various transitions are shown in Fig. 5a -c. When we followed cells with a homogenous distribution at the beginning of the recording, RILP coexpression increased the percentage of cells acquiring particles ( Fig. 5a and d) and decreased the cells that remained with a homogenous distribution throughout the recording (Fig. 5f ). This is consistent with the higher percentage of cells with particles found with RILP in steady state (Fig. 1e) . FYCO1 overexpression, in contrast, significantly increased the disappearance of fluorescent particles ( Fig. 5b and g ). This is consistent with the smaller number of cells with particles observed in steady-state ( Fig. 3a and b) . Moreover, FYCO1 decreased the occurrence of apoptosis in cells with particles ( Fig. 5c and h ). FYCO1 did not significantly change the number of cells that remained with particles throughout the recording (Fig. 5i ).
FYCO1 reduces a-synuclein amount and toxicity
To validate whether the observed reduction in visible a-synuclein particles is accompanied by a change in a-synuclein protein amounts, we carried out immunoblot analysis of HEK293T cells expressing A53T-a-synuclein and in addition RILP or FYCO1 (Fig. 6a, quantified in b) . Blots developed with an antibody against a-synuclein showed a specific band at the weight of the a-synuclein monomer among several non-specific bands. a-synuclein immunoreactivity was reduced on average by 50% with coexpression of FYCO1, whereas RILP did not lead to a significant change. Moreover, we aimed to validate the finding of the time-lapse experiment where FYCO1 reduced the occurrence of cell death in cells with a-synuclein aggregates (Fig. 5e ). For this we counted the percentage of living and dead cells using Trypan blue (Fig. 6c) . In HEK293T cells, transfection with A53T-asynuclein led to a small but reproducible increase in the number of dead cells. This a-synuclein-dependent toxicity was blocked by cotransfection of FYCO1 but not mCherry or RILP.
Electron microscopic analysis
In order to gain more detailed insights into the subcellular distribution of a-synuclein aggregates and the consequences of FYCO1 over-expression, we carried out electron microscopic studies. Untransfected HEK293T cells (Fig. 7a-c with regular ultrastructures and showed no extracellular electron-dense protein aggregates. HEK293T cells overexpressing EGFP-tagged A53T-a-synuclein (Fig. 7d-i ) exhibited accumulated glycogen (asterisks in Fig. 7d and h) and vesicles (arrow in Fig. 7e ). These cells showed a build-up of autophagosomes (black arrows in Fig. 7d and f). They also showed small (arrow in Fig. 7g ) and large (arrow in Fig. 7h ) vacuoles and electron-dense aggregated material (white arrows in Fig. 7d ). The fact that the aggregated material was only observed with a-synuclein over-expression indicates that the aggregated material contains a-synuclein. There are, however, other possible explanations. We also observed an increased occurrence of apoptotic cells (arrow in Fig. 7i ), which is in line with increased cell death as observed by timelapse microscopy ( Fig. 5e ) and Trypan blue staining (Fig. 6c) . When FYCO1 was coexpressed with A53T-a-synuclein (Fig. 7j-q) , prominent Golgi structures (white arrow in Fig. 7j) were detectable in the vicinity of electron-dense material (black arrow in Fig. 7j ), most likely corresponding to protein aggregates. Additionally, protein aggregates (black arrow in Fig. 7k ) surrounded by rough endoplasmic reticulum (white arrows in Fig. 7k ) and lysosomes (asterisks in Fig. 7k) were detectable. Moreover, autophagosomes and small vacuoles filled with electron-dense material were more frequently detectable with FYCO1 over-expression (black arrows in Fig. 7l-n) . These vacuoles were occasionally localized near prominent Golgi structures (white arrow in Fig. 7n) . In several instances, exocytosis of electron-dense material could be identified upon the coexpression of FYCO1 (grey arrows in Fig. 7m-q) .
Possible secretion of a-synuclein
The location of FYCO1-positive vesicles close to the cell surface (Fig. 2c ) and the observation of extracellular electron-dense material in cells over-expressing FYCO1 as observed by electron microscopy ( Fig. 7m-q) indicate that FYCO1 might stimulate a-synuclein secretion. FYCO1 has been implicated in a pathway that leads to fusion of endolysosomal vesicles with the plasma membrane. When coexpressed with protrudin, FYCO1 increased the fusion of LAMP1-positive membranes with the plasma membrane (Raiborg et al. 2015) . This fusion can be detected by expressing a LAMP1 construct tagged with a GFP variant on the luminal side and with mCherry on the cytoplasmic side followed by staining of cells fixed without permeabilization by a primary antibody against GFP and an Alexa633-coupled secondary antibody (Medina et al. 2011; Raiborg et al. 2015) . Using the same methodology, we tested whether FYCO1 induces increased fusion of endolysosomal membranes with the plasma membrane in our system (Fig. 8a-e) . Cells expressing GFP-LAMP1-mCherry alone (Fig. 8a ) or together with a-synuclein (Fig. 8b) showed GFP antibody staining (green) at the cell membrane and mCherry-positive structures in the cytosol. With coexpression of FYCO1, the GFP staining at the plasma membrane became more patchy (Fig. 8c) , similar to the GFP staining described by others (Medina et al. 2011) . For quantification, we calculated the amount of LAMP1 in the plasma membrane (Alexa633 fluorescence) relative to total LAMP1 (mCherry fluorescence). Although a-synuclein expression itself did not have any effect, coexpression of FYCO1 in the presence of asynuclein was able to induce a significant increase in the Alexa633/mCherry ratio (Fig. 8d) suggesting an increase in the fusion of endolysosomal membranes with the plasma membrane.
Taken together, we have demonstrated that with FYCO1 coexpression, aggregated material can be found in the extracellular space, and lysosomal membranes fuse with the plasma membrane. We therefore hypothesized that FYCO1 may induce secretion of a-synuclein. To test this, we measured extracellular a-synuclein by ELISA. We found more a-synuclein in the medium of cells transfected with A53T-a-synuclein than in the medium of control cells, consistent with constitutive a-synuclein secretion (Fig. 8e) . Coexpression of FYCO1 with a-synuclein did, however, not change the absolute amount of extracellular a-synuclein. When we calculated relative a-synuclein secretion as the ratio of extracellular a-synuclein measured by ELISA (Fig. 8e) and intracellular a-synuclein measured by immunoblots (Fig. 6b) , the ratio of extracellular to intracellular asynuclein was larger with FYCO1 (Fig. 8f ). Yet, this observation is very indirect and the difference is small, so further experiments are required to determine whether FYCO1 induces a-synuclein secretion.
FYCO1 rescues a-synuclein-induced locomotor deficits in flies Since FYCO1 reduced intracellular a-synuclein and increased fusion of lysosomal membranes with the plasma membrane, we aimed to determine the net effects of FYCO1 over-expression in an intact organism. To this end, we used Drosophila melanogaster flies with mild pan neural expression of human A53T-a-synuclein. Flies are an established model for PD and have been frequently used to assay modulators of a-synuclein-induced toxicity (Feany and Bender 2000) . The fly model we used does not show a reduced lifespan but exhibits a progressive reduction in locomotion in the 'climbing assay' (Butler et al. 2012; Dinter et al. 2016) . We thus analysed locomotion of flies expressing in neurons one copy of A53T-a-synuclein and in addition either FYCO1 or GFP. Young flies (5 days old) from both groups showed an almost perfect climbing ability ( Fig. 9a) . At the age of 15 days, flies coexpressing GFP with A53T-a-synuclein showed a significant decline in climbing activity as compared to day 5, which was not the case for flies expressing FYCO1 with A53T-a-synuclein (two-way ANOVA and Dunnet's post hoc test). At 25 days, the climbing ability was decreased even more strongly in control flies, but not statistically different from the age of 5 days in FYCO1 coexpressing flies (two-way ANOVA and Dunnet's post hoc test). Thus, FYCO1 successfully rescued the onset of the A53T-a-synuclein-induced motor phenotype in this fly model of PD. Furthermore, we aimed to determine whether the rescue of the a-synuclein-induced motor deficit by FYCO1 was correlated with a reduction in a-synuclein aggregates. For that purpose, we used flies expressing two copies of A53T-asynuclein. Large aggregates of a-synuclein were quantified by the 'filter trap' assay where lysates of fly heads are passed through a membrane and the amount of a-synuclein aggregates retained in the membrane is detected by an a-synuclein antibody. We found that the amount of large a-synuclein aggregates was significantly smaller in lysates from flies coexpressing FYCO1 with A53T-a-synuclein than in lysates from control flies (Fig. 9b and c) . This finding confirms that in neuronal cells of an intact animal, FYCO1 is able to reduce the amount of high molecular weight a-synuclein aggregates.
Discussion
In this study, we demonstrated that over-expression of the Rab7 effector FYCO1 induces clearance of a-synuclein aggregates and reduces the a-synuclein-induced locomotor deficit in a D.melanogaster model of PD. The FYCO1 effect requires Rab7, confirming that FYCO1 acts as a Rab7 effector. Conversely, the clearance of aggregates induced by Rab7 is diminished by knockdown of FYCO1, indicating that FYCO1 is one of the players mediating the Rab7-induced aggregate clearance we had previously observed (Dinter et al. 2016) . RILP over-expression on the other hand did not reduce a-synuclein aggregates in HEK293T cells, nor did its knockdown prevent the Rab7 effect.
RILP does not mediate Rab7-induced aggregate clearance in HEK293T cells Vesicular structures labelled by RILP did not associate with a-synuclein (Fig. 1a) . Over-expression of RILP increased the number of cells with a-synuclein aggregates in steady state (Fig. 1b and c) and it facilitated the formation of new aggregates as observed by time-lapse microscopy ( Fig. 5a) . Accordingly, RILP did not decrease a-synuclein amount ( Fig. 6a and b) or toxicity (Fig. 6c) . Moreover, knockdown of RILP did not reduce the Rab7-mediated reduction of a-synuclein aggregates. (Fig. 1a and b) .
Our finding that RILP over-expression had no beneficial effect on autophago-lysosomal aggregate clearance was unexpected given the important role of RILP for lysosomal degradation of other substrates, including EGF receptor and LDL (Cantalupo et al. 2001) and its involvement in chaperone-mediated autophagy (Zhang et al. 2017 ). Yet, RILPdependent EGF receptor degradation was supported by Rab7 mutants associated with Charcot-Marie-Tooth (CMT) neuropathy (Spinosa et al. 2008 ), whereas we previously observed that the CMT-associated Rab7 mutants did not support aggregate clearance (Dinter et al. 2016) . We therefore hypothesize that molecular requirements differ between degradation of endosomal cargo such as EGF receptor and LDL and autophagosomal cargo such as a-synuclein aggregates. RILP and the CMT-associated Rab7 mutants appear to support endosomal but not autophagosomal degradation. One hypothesis to explain the negative effect of RILP over-expression on aggregate clearance could be that overexpressed RILP sequesters Rab7 and thereby inhibits other Rab7 effectors. Accordingly, it was shown previously that RILP over-expression reduced the number of FYCO1-decorated vesicles (Pankiv et al. 2010) . However, even DN Rab7 did not increase the prevalence of aggregates much ( Fig. 4a and Dinter et al. 2016) ; therefore rendering this mechanism unlikely to explain the RILP effect. Another hypothesis could be to speculate that an increased transport of vesicles towards the MTOC induced by RILP inhibits aggregate clearance, especially given that FYCO1 overexpression, which has a beneficial effect, induces transport of vesicles in the opposite direction. Iguchi et al. (2016) , showed that blocking the secretion of TDP-43-containing exosomes in Neuro2A cells led to an increase in TDP-43 cytoplasmic aggregates. It is therefore also possible that the observed RILP effect is mediated through a decrease in a-synuclein secretion caused by the increase in vesicle transport towards the MTOC. Certainly, further studies are required to resolve why RILP over-expression reduces aggregate clearance, but we can conclude that RILP is unlikely to mediate Rab7-induced aggregate clearance in HEK293T cells.
It has been shown that inhibition of dynein-dependent transport towards the MTOC led to accumulation of a-synuclein (Ravikumar et al. 2005) . The increase in a-synuclein aggregates by RILP knockdown can therefore be explained by the fact that RILP mediates dynein binding to autophagosomes (Jordens et al. 2001; Johansson et al. 2007 ).
FYCO1 mediates Rab7-induced aggregate clearance FYCO1 is a known Rab7 effector (Pankiv et al. 2010) . Overexpressed FYCO1 labelled vesicular structures containing a-synuclein, (Fig. 2c) and affected a-synuclein in a similar manner to Rab7: It decreased the amount of a-synuclein particles in steady-state ( Fig. 3a and b) , caused frequent disappearance of a-synuclein particles during 12 h as observed by time-lapse microscopy ( Fig. 5d) , decreased a-synuclein amounts ( Fig. 6a and b) and decreased a-synuclein-induced toxicity (Figs 5e, 6c ). FYCO1 requires Rab7 for its effect since it is blocked by DN Rab7 (Fig. 4a) . Conversely, the Rab7 effect is reduced by FYCO1 knockdown (Fig. 3c) . We therefore conclude that FYCO1 participates in the Rab7-induced aggregate clearance.
The identification of FYCO1, a factor facilitating transport towards the cell periphery, as the Rab7 effector mediating aggregate clearance was unexpected since previous work has mainly identified transport towards the MTOC as important for the clearance of protein aggregates. Protein aggregates not confined by a membrane are transported towards the MTOC where they form the aggresome (Lamark and Johansen 2012) , whereas autophagosomes are considered to form in distal axons or throughout the cytosol and move towards the MTOC (Jahreiss et al. 2008; Maday et al. 2012) . Inducing lysosome transport towards the MTOC by knockdown of Arl8 increased autophagy. Inducing lysosome transport towards the cell periphery by over-expression of Arl8 had the opposite effect; it reduced colocalization of LC3 and LAMP1, decreased acidification of LC3-RFP-GFP and increased the amount of EGFP-A53T-a-synuclein (Korolchuk et al. 2011 ).
Yet, induction of transport towards the cell periphery is not the only effect of FYCO1. FYCO1 was recently shown to contribute to the maturation of autophagosomes and phagophores through its LIR domain (Ma et al. 2014; Olsvik et al. 2015; Dionne et al. 2017 ). Indeed, rare FYCO1 variants some of which contain missense mutations in the LIR domain have recently been associated with inclusion body myositis (G€ uttsches et al. 2017) a disease characterized by accumulation of protein aggregates and suspected impaired autophagic degradation. FYCO1 may also contribute to lysosome tubulation, a step leading to lysosome reformation (Mrakovic et al. 2012) . Further research will therefore be necessary to clarify the pathway by which FYCO1 mediates aggregate clearance and the question to what extent FYCO1 is required for baseline autophagic flux. In our hands, over-expressing FYCO1 demonstrated improved clearance of a-synuclein aggregates, but FYCO1 knockdown did not lead to an accumulation of a-synuclein aggregates ( Fig. 3d and e) , neither did DN Rab7 (Fig. 4 , Dinter et al. 2016) . Accordingly, Dionne et al. (2017) saw no major defect in baseline autophagic flux in HeLa cells with FYCO knockdown.
a-Synuclein secretion
It is possible that FYCO1 reduces a-synuclein aggregates by increasing a-synuclein secretion. Constitutive secretion of a-synuclein was demonstrated by ELISA measurements of a-synuclein in the cell culture supernatant of cells expressing a-synuclein (Fig. 8e) , consistent with a large body of evidence supporting this (Emmanouilidou et al. 2011; Tyson et al. 2016) . Increased secretion of a-synuclein with FYCO1 over-expression is supported by the extracellular electrondense material observed with electron microscopy (Fig. 7m-q) and the increased insertion of endolysosomal membranes into the plasma membrane (Fig. 8d) . The latter finding reproduced earlier findings by others in PC12 cells, even though coexpression of protrudin with FYCO1 was required in that study (Raiborg et al. 2015) . This could represent a potential route for a-synuclein secretion. However, the absolute amount of extracellular a-synuclein was not increased with FYCO1 over-expression as measured by ELISA (Fig. 8e) . Moreover, the amount of a-synuclein aggregates isolated from fly heads was reduced in the presence of FYCO1 (Fig. 9b and c) , suggesting that the net effect of FYCO1 over-expression is a reduction of a-synuclein aggregates. However, in the environment of the fly brain, one cannot exclude that extracellular a-synuclein is cleared by proteolysis or taken up and cleared by neighbouring cells (Lee et al. 2008; Park and Kim 2013) .
Conclusions
We have demonstrated that a pathway of Rab7 and FYCO1 can induce clearance of A53T-a-synuclein aggregates in HEK203T cells and flies. Similar to Rab7, FYCO1 overexpression is well tolerated, reduces aggregate load and rescues the onset of the A53T-a-synuclein-induced locomotor defects in a fly model of PD, confirming that the Rab7-FYCO1 pathway is a promising therapeutic strategy. The downstream mechanism by which Rab7-FYCO1 induce aggregate clearance still remains to be determined, and our findings need to be confirmed in mammalian neurons.
